Lexeo wins fast track designation for Friedreich’s ataxia gene therapy
Clinical-stage genetic medicine company Lexeo Therapeutics has won fast track designation from the US Food and Drug Administration (FDA) for…
All articles by Jenna Philpott
Jenna Philpott
Jenna Philpott is a trainee healthcare and pharmaceutical reporter. Coming from a scientific background, Jenna has expertise in biochemistry, genetics and cancer science. Jenna previously wrote freelance articles focused on oncology and healthcare.
-
-
Two major breakthroughs in Fragile X Syndrome treatments
Spinogenix has received approval from the US Food and Drug Administration (FDA) for a Phase II clinical trial of SPG601…
-
Soligenix bags orpan drug designation for Marburg virus vaccine
The US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient in MarVax, Soligenix’s vaccine…
-
FDA approves new administration routes for Xcopri
South Korea-based SK Life Sciences has received US Food and Drug Administration (FDA) approval for two new forms of administration…
-
UK’s NICE recommends AbbVie’s Aquipta to treat migraines
The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending the use of AbbVie’s…
-
Innate Pharma plans IND of ADC candidate after positive preclinical data
Innate Pharma has announced positive preclinical data of its antibody-drug conjugate (ADC) candidate IPH45, as it plans to advance the…
-
Oryzon wins FDA approval to begin SCLC treatment trial
Oryzon Genomics is set to commence a Phase I/II clinical trial of iadademstat (ORY-1001) plus immune checkpoint inhibitors (ICI) in…
-
FDA accepts Shorla’s oral liquid leukaemia drug NDA
A new drug application (NDA) from US-Ireland speciality pharmaceutical company Shorla Oncology has been accepted by the US Food and…
-
Amylyx axes ALS drug from market after Phase III failure
Amylyx Pharmaceuticals has formally announced the removal of its amyloid lateral sclerosis (ALS) drug Relyvrio (AMX0035) from the market following…
-
Touchlight joins forces with University of Liverpool for NSCLC vaccine
UK-based CDMO Touchlight has teamed up with the University of Liverpool, UK, to utilise its doggybone DNA (dbDNA) technology in…